Pharmaceutical company Pfizer reports that testing of a new coronavirus vaccine may happen next week. If everything goes according to schedule, then by the end of autumn it can be used for emergency testing.
“We know that this issue excites everyone, and we are working on it,” commented Pfizer CEO Albert Bourla in an interview with the Wall Street Journal. Pfizer works together with the German company BioNtech. According to the latest data, clinical trials on human volunteers in Germany are already underway.
The US health care system may approve vaccine testing by next week. If everything goes according to schedule, and the results are positive, then by the beginning of autumn the vaccine will begin to be used for emergency cases.
The New York Corporation sponsored $ 650 million in the development and production and future distribution of the COVID-19 vaccine.